trial

Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders

NCTId NCT03649581
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 84 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2027-02-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
84 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2019-02-28
Primary completion
2027-02-02
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
compare the two groups of schizophrenic patientscompare the two groups of schizophrenic patients versus volunteers

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
84
Phase
NA
Primary Completion Date
2027-02-02
Status
RECRUITING
relationships
The graph out of here
drug
compare the two groups of schizophrenic patients
drug
compare the two groups of schizophrenic patients versus volunteers
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia
indication
Schizophrenia
indication